Previous 10 | Next 10 |
2023-06-30 14:33:54 ET Biotricity Holdings ( NASDAQ: BTCY ) said on Friday that it will effect a reverse stock split of it common stock, effective after markets open on July 3. BTCY shares up +2.1%. "At the effective time of the reverse stock split, every 6 shares of B...
REDWOOD CITY, CA / ACCESSWIRE / June 30, 2023 / Biotricity Holdings, Inc. ("Biotricity" or the "Company") (NASDAQ:BTCY), a medical diagnostic and consumer healthcare technology company, today it will effect a reverse stock split of its common stock. Biotricity expects its common stock to begin t...
Company advancing toward positive cashflow likely by end of CY 2024 Accelerating product sales, and customer re-order revenue, FY23 revenue rose 26% YOY to $9.64 million on 5% lower SG&A of $17.6 million Improving gross margins currently at 57% despite reduced, loss-leader devi...
The Company recently announced reaching a record $13 million annualized revenue run rate in April 2023 REDWOOD CITY, CA / ACCESSWIRE / June 26, 2023 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a leading medical diagnostic and consumer healthcare technology company, ann...
2023-05-24 14:11:26 ET In its preliminary annual 2023 Russell indexes reconstitution, a total of 164 companies will be added and 319 deleted from the Russell microcap index. Following notable industrial companies will be added and deleted from Russell microcap index. Notable additions...
Company's proprietary AI technology allows for expansion into predictive monitoring and new disease profiling The New England Journal of Medicine article cites AI and its potential for increased healthcare efficiency and insights REDWOOD CITY, CA / ACCESSWIRE / May 23, 2023 / Dr. Waqaas...
2023-05-16 10:23:33 ET Consumer healthcare technology company Biotricity ( NASDAQ: BTCY ) said on Tuesday that its April annualized revenue run rate reached $13M, compared to the $12M run rate for March. The company anticipates continued topline revenue growth, along with cont...
Corporate Impact Report concluded better patient outcomes and substantial cost savings for patients using Company's devices REDWOOD CITY, CA / ACCESSWIRE / May 16, 2023 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a leading medical diagnostic and consumer healthcar...
Dr. Waqaas will address, meet with, world leaders and medical innovators on pressing challenges and solutions in global cardiovascular health, digital health and AI REDWOOD CITY, CA / ACCESSWIRE / May 10, 2023 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a leading med...
REDWOOD CITY, CA / ACCESSWIRE / April 21, 2023 / Biotricity Inc. (NASDAQ:BTCY), a medical technology company committed to improving healthcare by developing solutions that aid in chronic disease prevention and management, is taking action to tackle the unmet need in cardiovascular diseases (CV...
News, Short Squeeze, Breakout and More Instantly...
ORLANDO, FL / ACCESSWIRE / July 12, 2024 / RedChip Companies will air interviews with Biotricity, Inc. (Nasdaq:BTCY) and bioAffinity Technologies, Inc. (Nasdaq:BIAF) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, July 13, at 7 p.m. East...
REDWOOD CITY, CA / ACCESSWIRE / July 11, 2024 / Biotricity Inc. (NASDAQ:BTCY), a Technology-as-a-Service (TaaS) company operating in the remote cardiac monitor sector of consumer healthcare, today announced its accelerated timeline to achieving EBITDA positive. The company now expects to reach t...
REDWOOD CITY, CA / ACCESSWIRE / July 10, 2024 / Biotricity Inc. (Nasdaq:BTCY), a Technology-as-a-Service (TaaS) company operating in the remote cardiac monitor sector of consumer healthcare, today announced the launch of a new cardiac monitoring pilot program with a prominent hospital group enco...